Diabetes, Vol 38, Issue 4 428-434, Copyright © 1989 by American Diabetes Association
Coordinate decrease of tissue insulinlike growth factor I posttranscriptional alternative mRNA transcripts in diabetes mellitus
JA Fagin, CT Roberts, D LeRoith and AT Brown
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.
In these studies, we examined the effect of excess levels of growth hormone
(GH) on rat insulinlike growth factor I (IGF-I) gene expression in
streptozocin-induced diabetes mellitus. A solution hybridization/RNase
protection assay was used to simultaneously quantitate the relative tissue
content of the variant IGF-I mRNA species arising from alternative splicing
in the region encoding the COOH-terminal extension E-peptide (IGF-Ia and
IGF-Ib). IGF-Ia and IGF-Ib mRNAs were markedly decreased in liver, kidney,
and lung tissues of diabetic rats. Although GF stimulates IGF-I gene
expression, chronic GH excess from implanted somatomammotropic tumors did
not appropriately induce tissue IGF-I mRNA content in diabetic animals.
Treatment of diabetic rats with insulin for 1 wk restored basal and
GH-stimulated IGF-Ia and IGF-Ib mRNA content toward that present in tissues
of nondiabetic rats. The ratio of IGF-Ia to IGF-Ib mRNA remained relatively
constant for each tissue and was not affected by the diabetic state,
chronic GH hyperstimulation, or insulin therapy, suggesting that
posttranscriptional splicing is not a regulated event in these conditions.
Thus, both circulating IGF-I levels and tissue IGF-I gene expression are
profoundly decreased in this model of experimental diabetes. Diminished
tissue availability of IGF-I from endocrine and/or paracrine sources may be
responsible for the growth retardation seen in uncontrolled diabetes
mellitus.